New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

en_US EN
en_US EN es_MX ES

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

NephCure Kidney Health Quiz

  • This field is for validation purposes and should be left unchanged.
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7

  • Welcome to the Kidney Risk Quiz

    More than 1 in 7 Americans have Chronic Kidney Disease (CKD), but up to 90% do not know they have it. Be proactive and take control of your health by staying aware of your risk for kidney disease. This information is helpful for you and your loved ones to maintain your overall health.

  • Select one of the following:
  • Select one of the following:
  • Please select all that apply.
  • Please select all that apply.
  • Please select all that apply.

  • Your Results Are In!

    Provide your email address so we can send you a copy of your quiz results and tips for helping you or your loved one prevent kidney disease. Click “Skip Email” to view your results without receiving an emailed copy.

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.
NephCure Logo

INTRO TO RKD

Overview
Types of RKD
Navigating New Diagnosis
Pediatric Care
End-Stage Kidney Disease

SUPPORT

Patient Navigation Services
Online Patient Community
Patient Stories
Support Groups
Resources

MANAGING RKD

Find a Specialist
Clinical Trials
Treatment Options
RKD & Mental Health
Diet & Nutrition
Genetic Testing

LEGAL

Careers
Privacy Policy
Policies & Disclaimers
Financials

ABOUT US

Our Impact
What We Do
Team
Current Partnerships
News
Contact Us

GET INVOLVED

Volunteer
Events
Advocacy
Find your Local Community
Ways to Give

Our Mission

NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible.

Find Us On

NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.